Ensign Group

Ensign Group is a holding company. Through its operating subsidiaries, the company provides skilled nursing, senior living and rehabilitative services, as well as other ancillary businesses. In transitional and skilled services, the company provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly. The company's senior living companies provide residential accommodations, activities, meals, housekeeping and assistance in the activities of daily living to seniors who are independent or who require some support, but not the level of nursing care provided in a skilled nursing operation. The company's other business lines includes of mobile ancillary services.
  • TickerENSG
  • ISINUS29358P1012
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

ENSIGN GROUP sees an upgrade to Neutral thanks to a better star rating, but the title remains unattractive

The independent financial analyst theScreener just awarded an improved star rating to ENSIGN GROUP (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 1 out of 4 possible stars. Given its market behaviour as moderately risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Neutral; the title, however, remains unattractive. As of the analysis date June 8, 2021, the closing price was USD 83.81 and its target price was estimated at USD 68.06.

Ensign Group Inc: 1 director

A director at Ensign Group Inc sold 8,000 shares at 90.760USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boar...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500, Russell 2000 Testing Short-Term Support Ongoing market dynamics remain largely positive and there continues to be an absence of major breakdowns across all Sectors and the major averages. As a result, we expect higher prices ahead and recommend adding exposure on pullbacks. · S&P 500, Russell 2000. The S&P 500 and Russell 2000 (IWM) have pulled back to short-term support at their prior downtrends -- 3880-3890 on SPX and $222-223 on the IWM. If this level fails to hold on the SPX, the next important support levels come in at 3755 followed by 3723; as long as 3723 holds we are...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of names in the Communications Sector are showing signs of leadership. (ex. GLUU, TWTR, GOOGL, NYT, and NWSA) • Consumer Discretionary continues to have a number of attractive names technically. (ex. TPR, LGIH, DHI, VSTO, RGR, PENN, SGMS, BYD, BJRI, BKE, EBAY, SIG, HAIN, and ENR ) • A number of Financial Sector names appear to be perking up. (ex. JHG, INTL, EVR, GHL, ARR, and CINF)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: Home builders and suppliers continue to outperform and one supplier, MHK, appears to be bottoming. A number of Financial names continue to plod up and to the right (e.g. AMP, AXP, MSCI, RNR) The Technology Sector remains leadership and many names continue to outperform (e.g. SEDG, SNPS, ADBE, TTEC, GPN, PYPL)

Ensign Group Inc: 1 director

A director at Ensign Group Inc sold 8,000 shares at 90.760USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boar...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500, Russell 2000 Testing Short-Term Support Ongoing market dynamics remain largely positive and there continues to be an absence of major breakdowns across all Sectors and the major averages. As a result, we expect higher prices ahead and recommend adding exposure on pullbacks. · S&P 500, Russell 2000. The S&P 500 and Russell 2000 (IWM) have pulled back to short-term support at their prior downtrends -- 3880-3890 on SPX and $222-223 on the IWM. If this level fails to hold on the SPX, the next important support levels come in at 3755 followed by 3723; as long as 3723 holds we are...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Large-Cap Growth Playing Catch-Up Our outlook remains bullish and we continue to view any weakness as a buying opportunity. Our bullish outlook is supported by continued positive market dynamics and the fact that the S&P 500 and Nasdaq 100 are holding above key support levels. · S&P 500, Nasdaq 100. Key support levels we are watching on the S&P 500 remain unchanged; immediate short-term support is in the 3630-3645 zone, with the next important support levels coming in at 3588 and 3550. As long as 3550 holds, we believe a bullish intermediate-term outlook is appropriate. As for the Nasd...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breakout Brewing? With the 3200-3230 support level holding strong on the S&P 500, we remain constructive over the intermediate-term as outlined in our 11/3/20 Compass. Considering current market dynamics we see eventual decisive breakouts as the most likely outcome for the major averages, which justifies our positive outlook. At the same time, with the S&P 500, Russell 2000, and Nasdaq 100 climbing 7-12% in just over a week and all three testing logical resistance, we believe there is potential for some near-term backing-and-filling. Continue to buy dips. · Testing Resistance. Both t...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ENSIGN GROUP sees an upgrade to Neutral thanks to a better star rating, but the title remains unattractive

The independent financial analyst theScreener just awarded an improved star rating to ENSIGN GROUP (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 1 out of 4 possible stars. Given its market behaviour as moderately risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Neutral; the title, however, remains unattractive. As of the analysis date June 8, 2021, the closing price was USD 83.81 and its target price was estimated at USD 68.06.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch